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Mycobacterium tuberculosis associated with severe
tuberculosis evades cytosolic surveillance systems
and modulates IL-1β production
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Genetic diversity of Mycobacterium tuberculosis affects immune responses and clinical out-
comes of tuberculosis (TB). However, how bacterial diversity orchestrates immune responses
to direct distinct TB severities is unknown. Here we study 681 patients with pulmonary TB
and show that M. tuberculosis isolates from cases with mild disease consistently induce robust
cytokine responses in macrophages across multiple donors. By contrast, bacteria from
patients with severe TB do not do so. Secretion of IL-1β is a good surrogate of the differences
observed, and thus to classify strains as probable drivers of different TB severities. Fur-
thermore, we demonstrate that M. tuberculosis isolates that induce low levels of IL-1β pro-
duction can evade macrophage cytosolic surveillance systems, including cGAS and the
inflammasome. Isolates exhibiting this evasion strategy carry candidate mutations, gen-
erating sigA recognition boxes or affecting components of the ESX-1 secretion system.
Therefore, we provide evidence that M. tuberculosis strains manipulate host-pathogen inter-
actions to drive variable TB severities.
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M ycobacterium tuberculosis is estimated to infect aquarter of the human population1 and to kill >1.5million people every year2. During its parallel evolu-
tion with the human host3, M. tuberculosis developed important
immune evasion mechanisms, including virulence factors aimed
at preventing elimination by macrophages4, and strategies to
modulate T-cell responses to favor transmission5. M. tuberculosis
is an obligate human pathogen with no environmental reservoir,
and for which transmission relies on disease establishment6.
Thus, M. tuberculosis must create a balance between damaging
the host (virulence) and finding the opportunity to spread
(transmission)—a balance which is ultimately achieved by mod-
ulating the host immune response. Interestingly, some strains of
M. tuberculosis are more transmissible than others, and this
transmission potential varies in different human genetic back-
grounds7. Therefore, one can expect a relevant role for both host
and pathogen diversity in disease establishment and transmission,
through the modulation of host immune responses.
The human adapted tuberculosis (TB)-causing bacteria are part
of the Mycobacterium tuberculosis complex (MTBC), and can be
divided into seven distinct lineages that exhibit a strong phylo-
geographical structure6. Despite harboring little DNA sequence
variation as compared to other bacteria8, strains of the MTBC
differ in their capacity to modulate the immune response9.
Pathogen diversity within the MTBC also impacts the clinical
manifestation of TB7,9. What remains unknown, however, is the
interaction between pathogen-induced immune-modulation and
disease severity. In other words, how does the natural diversity in
M. tuberculosis isolates direct the host immune response towards
a certain TB presentation. We studied well-defined patient and
pathogen populations to disclose the relevant immune responses
leading the various disease outcomes. Through genomic, tran-
scriptional, and functional analyses we propose that phylogen-
etically related M. tuberculosis isolated from severe TB cases
develops mechanisms to escape cytosolic recognition and con-
sequently lower cytokine production by host cells. This study
contributes to our understanding of the modulation of host
immunity to TB, with the potential to inform the design of host-
directed and pathogen-directed therapies for this devastating
disease.
Results
TB cohort characterization. To investigate whether M. tuber-
culosis-associated determinants may contribute to the pathogen-
esis of TB through the manipulation of host immune responses,
we started by stratifying TB severity in a fully characterized
population of TB patients10. From a cohort of 813 culture-
positive TB cases10, 681 adult pulmonary TB patients were
selected (Supplementary Fig. 1a) and classified according to the
absence or presence of risk factors for TB (Fig. 1a). To exclude the
effect of host-related comorbidities on TB presentation, we next
focused on TB only patients. The genetic ancestry of 60 TB
patients (Supplementary Fig. 1a) was investigated through a
validated panel of autosomal ancestry-informative markers
(AIMs). This analysis was performed alongside reference gen-
omes of African, European, East Asian and Native American, as
well as a group of Portuguese reference genomes11,12 and a group
of TB contacts from Porto (Fig. 1b). The ancestry of both the
Porto-TB contacts and the Porto-TB cohort seemed homo-
geneous, rooted on Portuguese and European makeups. Next,
based on chest X-ray classification and systemic parameters
(Fig. 1c and Supplementary Fig. 1b13), a clinical decision system
to assign the severity of TB at presentation was developed and
applied to the 133 TB cases, for which all required data was
available (Supplementary Fig. 1a). The most common TB
presentation was moderate, followed by mild and severe (Fig. 1d).
Although a higher proportion of men was observed in the severe
TB group, both the age of the patient and reported time of
symptoms were similarly distributed within the three TB severity
groups Supplementary Fig. 1c). In parallel, we recovered the
infecting M. tuberculosis isolates (Supplementary Fig. 1a) and
investigated the genetic structure of the bacteria population. A
large predominance of the MTBC L4 and of sublineage L4.3/LAM
was revealed within the pathogen population (Fig. 1e), in line
with other reports focused in Europe14,15. The pathogen popu-
lation structure was replicated across the different TB severity
groups (Fig. 1f).
Severe TB-associated M. tuberculosis induce lower cytokine
response. Our findings suggested that host-pathogen sympatry
breaks do not likely explain differences in the severity of TB in the
cohort under study. We then questioned whether M. tuberculosis
isolated from patients presenting different TB severities interacted
differently with human immune cells. For this, we selected L4
isolates from the mild (n= 10), moderate (n= 9), or severe (n=
7) TB groups (Supplementary Table 1). Each of these isolates was
used to infect peripheral blood mononuclear cells (PBMC) from
unrelated donors. To control for the TB status of these control
donors, we accessed their interferon gamma release assay (IGRA)
results. This assay discriminates individuals who present T-cell
memory responses to M. tuberculosis (and are IGRA+ ) from
those who do not (and are IGRA–). For our assays, we used
PBMCs isolated from 8–10 donors who had been IGRA+ for >2
years, did not undergo preventive antibiotherapy and had no past
TB episode. We decided not to use cells from active TB patients,
as their cytokine responses are altered by the disease status. We
also did not use IGRA– donors, as within this population certain
individuals might present innate resistance to TB and altered
myeloid cell responses to infection16. The supernatants from the
infected cultures were collected 24 h post-infection and the
amounts of IL-12p40, IL-1β, IFN-β, and IL-10 quantified. Inter-
estingly, as compared to M. tuberculosis isolated from mild TB
cases, M. tuberculosis isolates associated with severe or moderate
forms of TB induced lower cytokine responses in infected PBMCs
(Fig. 1g). IFN-β secretion was below detection level for all cases.
Although PBMCs from different donors varied in their absolute
amount of cytokine production, the observed cytokine pattern
was primarily controlled by M. tuberculosis (Supplementary Fig.
2). These data suggest a pathogen-driven association between the
levels of cytokines triggered and TB severity.
M. tuberculosis SNPs associated with host responses. To search
for bacterial genomic determinants driving the differential cyto-
kine responses in PBMCs, the whole-genome sequence of the 26
M. tuberculosis clinical isolates was generated. A total of 3112
unique polymorphisms (SNPs and InDels) were found in com-
parison with the inferred sequence of the MTBC ancestor5. The
maximum pairwise distance between any two clinical isolates was
456 mutations, as expected for M. tuberculosis strains from the
same lineage9. Five possible transmission clusters were identified
(Supplementary Fig. 3a). Taking IL-1β as a proxy for low versus
high-cytokine responses and using 3077 genome-wide SNP
positions, no clear associations between phylogeny and IL-1β
induction were found (Fig. 2a). Unbiased comparative analysis
between the selected M. tuberculosis isolates revealed 21 genes
harboring polymorphisms shared exclusively by >5 low IL-1β-
inducing isolates and three genes harboring polymorphisms
shared exclusively by three high inducing isolates (Fig. 2b and
Supplementary Table 2).
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Fig. 1 M. tuberculosis clinical isolates associated with severe TB induce lower cytokine responses. a The clinical data for 681 adult pulmonary TB (pTB)
cases were reviewed and classified according to the absence or presence of comorbidities. b Top panel: genetic makeup through a validated panel of
autosomal ancestry-informative markers of reference populations of African, European, East Asian, and Native American biogeographical origin. Bottom
panel: the genetic ancestry for a group of 60 TB patients was determined, together with TB contacts from the same area and a reference Portuguese
population. Represented are European ancestry in blue, African in orange, East Asian in pink and Native American in purple. c Clinical decision system
developed to classify the severity of TB at presentation in mild, moderate or severe. d Patients who had no known comorbidities (n= 133) were classified
into mild, moderate, or severe TB cases at presentation. e M. tuberculosis isolates recovered for 117 of the 133 selected TB patients were classified into
lineages and those belonging to lineage 4 (L4) were further classified into L4.3/LAM, L4.1.1/X, L4.1.2/Haarlem or other lineage 4 sublineages. f Mild,
moderate, and severe TB cases, as determined in d, were stratified according to the sublineage, the infecting bacteria belonged to. Statistical analysis was
performed with Fisher’s exact test. g PBMC from 8-10 IGRA+ donors were infected with L4 M. tuberculosis isolated from mild (n= 10), moderate (n= 9),
or severe (n= 7) TB patients. An MOI of 1 was used and 24 h post-infection the amounts of secreted IL-1β, IL-12p40, IL-10, and IFN-β quantified.
Represented are bean plots for each cytokine. Black lines show the medians; white lines represent individual data points; polygons represent the estimated
density of the data. IFN-β was undetected for all conditions. Statistical analysis was performed with Pearson correlation; R and p-values were: IL-1β R
= –0.3471; R2= 0.1205; p < 0.00001; IL-12 R= –0.3419; R2= 0.1169; p < 0.00001; and IL-10 R= –0.1918; R2= 0.0368; p= 0.002473. CRP C-reactive
protein, Hb hemoglobin, LAM Latin-American and Mediterranean, N no, TB tuberculosis, Y yes.
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If some of the identified polymorphisms indeed lead to a
modulation of cytokine induction, we would expect signatures of
selection acting upon them. Homoplastic positions, those
appearing multiple times and independently in the phylogeny,
are generally good surrogates of the action of positive
selection17,18. By comparing the identified polymorphisms to a
collection of 4528 strain genomes representative of the global
diversity of the MTBC, we found that five SNP positions from our
Porto dataset also emerged in unrelated strains in the phylogeny
more than one time. Notably, we found a synonymous position
that occurred five times in strains from different lineages
(Supplementary Table 2). Although unlikely to alter the structure
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Fig. 2 Common polymorphisms in groups of low-cytokine-inducing M. tuberculosis clinical isolates. Genome-wide analysis was performed for 26 M.
tuberculosis clinical isolates with known IL-1β inducing profiles in human PBMCs. a Phylogenetic tree of the isolates constructed with genome-wide SNPs
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of the underlying protein, this synonymous mutation generates a
new internal TANNT sigA recognition box. We have shown
before that MTBC uses newly generated TANNT boxes as a way
to adapt to changing environments19. In fact, among the
synonymous SNPs observed, three generate new regulatory
TANNT boxes (Supplementary Table 2). Taken together, the
evolutionary analysis suggests that at least part of the poly-
morphisms and genes identified are under selection in epide-
miological settings.
Given the previous association of the ESX-1 secretion system
with cytokine responses, particularly IL-1β20, a directed analysis
to identify polymorphisms in this pathway was performed. We
found common genetic variants shared by 5 clinical isolates (6C4,
3A7, 1C7, 5F9, and 5D6) inducing low IL-1β levels, while absent
in high IL-1β inducers (Fig. 2c and Supplementary Table 3). In
particular, M. tuberculosis isolate 5D6 harbored two SNPs in
genes encoding ESX-1 secretion system components (EccD1 and
EspA) and isolates 6C4, 3A7, and 5F9 shared two SNPs in the
intergenic regions espR-Rv3850 and PPE35-Rv1919c (Fig. 2c). No
SNPs exclusive of either group of isolates were identified in the
other ESX-1 components or regulators encoding genes. Collec-
tively, our analyses support that low IL-1β induction results from
different evolutionary events and highlight the diversity of
bacterial genetic pathways possibly underlying the manipulation
of host responses towards low-cytokine production.
IL-1β modulation by M. tuberculosis is host independent. M.
tuberculosis isolates 6C4, 3A7, and 5F9 belong to a probable
transmission cluster (Supplementary Fig. 3a) and consistently
induce the secretion of low IL-1β by infecting cells, thus sug-
gesting a “stable phenotype”. Isolate 6C4 was selected as a
representative of this transmission cluster and of the low-cyto-
kine/severe TB group and M. tuberculosis 4I2 as a representative
of the high-cytokine/mild TB. The clinical and genetic differences
between these two isolates are listed in Supplementary Tables 1
and 4. Both isolates belong to the LAM sublineage of L4 and
showed similar growth curves in axenic media (Supplementary
Fig. 3b). We next measured the production of IL-1β induced
upon infection of cells from different origins with M. tuberculosis
isolate 4I2 or 6C4. Differential IL-1β induction was observed
upon infection of PBMCs from IGRA+ (Fig. 3a) or IGRA–
(Fig. 3b) donors, and upon infection of purified monocytes from
IGRA– individuals (Fig. 3c), macrophages differentiated from the
human monocytic cell line THP-1 (Fig. 3d) or mouse bone
marrow-derived macrophages (BMDMs; Fig. 3e). The differential
pattern of IL-1β expression is thus independent of the host and its
TB status, being instead strongly dictated by the infecting bac-
teria. Of note, the differential response observed was also inde-
pendent of the batch of M. tuberculosis, as stocks grown
independently yielded the same profile of IL-1β induction in
infected cells.
M. tuberculosis strain-dependent transcriptome modulation.
To gain insights on the mechanisms underlying the differential
cellular response to the selected M. tuberculosis isolates, a targeted
RNA Sequencing for gene expression analysis21,22 was obtained
for BMDMs before and after infection with either isolate. An
overall similarity between replicates and groups was detected for
genes with a > 2-log fold-change and a statistical difference
(adjusted p-values of ≤0.05) in expression upon infection (Sup-
plementary Fig. 4a, b). Principal component analysis (PCA)
showed that over 75% of the differences observed between sam-
ples, described by PC1, are mainly between BMDMs left unin-
fected and BMDMs infected with the 4I2 M. tuberculosis isolate
(Fig. 4a). In response to infection with M. tuberculosis isolate 4I2,
1.271 transcripts were differentially expressed by BMDM, against
only 389 transcripts detected in the case of isolate 6C4 (Fig. 4b, c).
Canonical pathway analysis (ReactomePA) revealed that whereas
infection with isolate 4I2 activated PRR-related pathways, such as
TLRs, NLRs, and MyD88 or TRIF cascades, infection with 6C4
did not (Fig. 4d, e). An overview of the interactions between the
activated pathways and the significantly altered genes in each
pathway upon infection is shown in Supplementary Fig. 4c, d.
Thus, infection with M. tuberculosis isolate 4I2 resulted in a more
robust and complex alteration of the gene expression profile of
host BMDMs than that induced by isolate 6C4.
Increased IL-1β secretion is due to inflammasome activation.
Differentially regulated genes within the cytokine/interleukin-
related pathways showed an overall higher expression in BMDMs
infected with M. tuberculosis isolate 4I2 (Fig. 5a). However, the
expression of Il1b was detected at the same level in BMDMs
infected with either isolate (Fig. 5a). This was validated by real-
time PCR in both BMDMs (Fig. 5b) and human CD14+
monocytes (Supplementary Fig. 5a). Furthermore, for both M.
tuberculosis isolates the production of IL-1β by infected BMDMs
was fully dependent on TLR2 activation (Fig. 5c), with no con-
tribution of TLR4 triggering (Supplementary Fig. 5b). Therefore,
the differences on secreted IL-1β by infected BMDMs likely result
from post-transcriptional events, perhaps through differential
inflammasome activation. To test this hypothesis, we used THP-
1-ASC-GFP reporter cells23. The percentage of ASC-speck-
positive cells in PMA-differentiated reporter cells was higher in
the case of M. tuberculosis 4I2 infections (Fig. 5d and Supple-
mentary Fig. 5c). Chemical inhibition of NLRP3 (Fig. 5e) or of
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caspase-1 (Fig. 5f) strongly abrogated IL-1β production by
BMDMs infected with M. tuberculosis isolate 4I2. Inhibition of
NLRP3 or caspase-1 during infection of macrophages with the
severe TB causing isolate (6C4) also decreased IL-1β secretion
(Fig. 5g, h). Therefore, the activation of NLRP3 is critical for the
secretion of IL-1β by BMDMs infected with either M. tuberculosis
isolate, but isolate 4I2 shows an enhanced ability to activate the
inflammasome.
To unveil the bacterial determinants of differential inflamma-
some activation, we firstly addressed possible differences in the
cell-wall lipidic fraction. The genomic data indicated that strain
6C4 harbored SNPs in genes encoding two key M. tuberculosis
lipids involved in virulence: sulfolipid-I and phthiocerol dimyco-
cerosate (PDIM), suggesting a potential change in the profiles of
these lipids. Lipid extracts of either bacteria were prepared
and analyzed by thin-layer chromatography (TLC). No major
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differences were observed in the lipid profiles of the two isolates,
with exception of free mycolic acids that appeared in relatively
higher amounts in M. tuberculosis isolate 4I2 (Supplementary Fig.
5d). To investigate if differences in the amount of cell-wall
components might explain the differential IL-1β response by
infected cells, we infected macrophages with increasing doses of
M. tuberculosis isolate 6C4. Even when a multiplicity of infection
(MOI) of 10 was used, the secretion of IL-1β was still low (Fig. 5i),
whereas that of TNF increased, showing that the macrophages
were upregulating their response to infection with higher doses of
M. tuberculosis 6C4 (Supplementary Fig. 5e).
To assess for a possible active inhibition of the inflammasome
and IL-1β production in cells infected with M. tuberculosis isolate
6C4, we next performed mixed infections of BMDMs. In these
infections, the total MOI was maintained at 2, but the amount of
M. tuberculosis isolate 4I2 was progressively replaced by isolate
6C4. Independently of the amount of isolate 6C4 present in
culture, the response of BMDMs toM. tuberculosis isolate 4I2 was
not inhibited (Fig. 5j). Furthermore, no inhibition was seen in
BMDMs infected with isolate 4I2 in the presence of supernatant
from cells infected with isolate 6C4 (Supplementary Fig. 5f).
Infection of BMDMs with M. tuberculosis isolate 6C4 did not
alter the transcription of key inflammasome components, as
revealed through the RNA-Seq data (Supplementary Fig. 5g).
Finally, infection of BMDMs with isolate 6C4 in the presence of
an inflammasome activator (as ATP), an upregulation of IL-1β
was observed (Fig. 5k). Altogether, this set of experiments
indicate that an intrinsic property of M. tuberculosis isolate 6C4
underlies the failure of this isolate to activate the inflammasome,
which is not related to the amount of bacteria required nor to a
direct inhibition of this pathway.
M. tuberculosis 6C4 evades cytosolic surveillance pathways. IL-
1β-inducing M. tuberculosis isolates accumulated mutations in
the ESX components or regulators (Fig. 2c). A competent ESX
system is required for the activation of the inflammasome20,24,25,
cGAS26–28, and RIG-I29 in M. tuberculosis-infected macrophages.
Thus, we next interrogated the global transcriptomic data for
differences in the activation of hallmark intracellular surveillance
pathways in macrophages infected with either M. tuberculosis
isolate. A higher upregulation of the genes associated with cGAS
(Fig. 6a), RIG-I (Supplementary Fig. 6a), TLR3 (Supplementary
Fig. 6b) or TLR7/8/9 (Supplementary Fig. 6c) pathways was
observed in BMDMs infected with M. tuberculosis isolate 4I2.
Hierarchical clustering for cGAS and RIG-I pathways showed
higher similarity between BMDMs infected with M. tuberculosis
isolate 6C4 and non-infected cells, than between the two infec-
tions (Fig. 6a and Supplementary Fig. 6a). The enhanced tran-
scription of the cGAS-associated genes Ifnβ, Il10, Ccl2, and Cxcl10
in BMDMs infected with M. tuberculosis isolate 4I2 was validated
by real-time PCR (Fig. 6b) and found to depend on the activation
of cGAS (Fig. 6c). Chemical inhibition of cGAS led to lesser
alterations on Tnf transcription (Fig. 6c).
The cGAS pathway is activated by bacterial DNA, which is
also a ligand for AIM2, a member of the inflammasome family
known to contribute to the secretion of IL-1β26–28. Therefore, it
is possible that the activation of AIM2 in BMDMs infected by
M. tuberculosis isolate 4I2 is contributing to maximal IL-1β
secretion. AIM2-/- BMDMs were generated and infected with
either isolate. The impact of AIM2 deficiency in the secretion of
IL-1β by macrophages infected with isolate 4I2 was more
pronounced than that seen in the case of infection with 6C4
(Fig. 6d). Phagosome rupture by mycobacteria triggers several
other molecular signals perceived by the NLRP3 inflamma-
some, among which K+ efflux and cathepsin B release30,31. In
further support of a more active or efficient phagosome rupture
induced by M. tuberculosis isolate 4I2, chemical inhibition of
K+ channels or of cathepsin B decreased the secretion of IL-1β
by 4I2-infected macrophages, while not affecting 6C4 infections
(Fig. 6e, f). Blocking bacterial phagocytosis using cytochalasin
D significantly compromised the secretion of IL-1β by BMDMs
infected with either M. tuberculosis isolate (Fig. 6g), showing
that intracellularly localized bacteria are required for IL-1β
secretion. Of note, the phagocytosis of the two M. tuberculosis
isolates by BMDMs occurred in a similar way (Supplementary
Fig. 6d), demonstrating that differential IL-1β induction did not
result from differences in bacterial internalization. Finally,
rifampicin treatment of M. tuberculosis isolate 4I2 decreased
the secretion of IL-1β by BMDMs, but had no effect in the case
of 6C4 isolate (Fig. 6h). Rifampicin treatment of M. tuberculosis
isolate 4I2 decreased the transcription of the Ifnb gene (Fig. 6i).
Therefore, internalization of live, transcriptionally competent
bacteria is required to induce maximal induction of IL-1β and
IFN-β.
The differential activation of the inflammasome and cGAS by
M. tuberculosis 4I2 versus 6C4 leads to the differential secretion of
IL-1β and IFN-β two cytokines involved in cross-regulatory
mechanisms32. To investigate whether this cross-regulation was
in place independently of the M. tuberculosis isolate, we
compared the response of IFNAR-/- BMDMs to that of
WT cells upon infection with isolate 4I2 or 6C4. Absence of
IFNAR further increased IL-1β secreted by BMDMs infected with
isolate 4I2, but did not impact IL-1β secretion upon infection
with 6C4 (Supplementary Fig. 6e). However, enhancing IFN-β
production by activating BMDMs infected with M. tuberculosis
isolate 6C4 with a RIG-I agonist decreased the secretion of IL-1β
by the infected cells (Supplementary Fig. 6f). Therefore, although
the mechanisms regulating the secretion of IL-1β and IFN-β are
still coupled, in certain situations they may depend on the
presence of other cellular sources of IFN-β to occur.
Collectively, our data suggest that M. tuberculosis isolates
differentially manipulate phagosome rupture and the activation
of several intracellular pattern recognition receptors, which
Fig. 4 M. tuberculosis isolate associated with severe TB modulates the macrophage transcriptome. BMDMs generated from C57BL/6 mice were
infected with M. tuberculosis isolates 4I2 or 6C4 at a MOI of 2, or kept non-infected (NI). Six hours post-infection cell cultures were lysed, RNA extracted
and subjected to targeted RNA-Seq. a Principal component (PC) analysis for data obtained from M. tuberculosis 4I2-infected (red), M. tuberculosis 6C4-
infected (blue) and non-infected (NI, yellow) cells. Venn diagram (b) and volcano plots (c) representing the significantly differentially expressed genes
(adjusted p-value≤ 0.05 and log(fold-change) ≥2 or≤ –2) when comparing BMDMs infected with M. tuberculosis isolate 4I2 or 6C4 with NI cells. In
c, significantly differentially expressed genes (NI versus infected cells; adjusted p-value≤ 0.05 and log(fold-change) ≥2 or≤ –2) are shown in orange.
Significant genes (adjusted p-value ≤0.05 and log(fold-change) between 2 and –2) are shown in black. Non-significant genes are displayed in light gray.
Pathway analysis for significantly expressed genes detected in BMDMs infected with M. tuberculosis isolate 4I2 (d) or 6C4 (e) versus NI cells. Bar plots
represent the number of genes present in each identified pathway and the color codes reflect adjusted p-values. In both differential expression analysis and
pathway analysis, multiple testing adjustments were performed using the Benjamini–Hochberg (BH) procedure. The 20 most affected pathways are
represented for each condition.
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Fig. 5 Induction of high IL-1β by M. tuberculosis 4I2 results from enhanced inflammasome activation. a Gene expression heatmap representing cytokine
expression for non-infected BMDMs (NI, yellow) and BMDMs infected with M. tuberculosis isolate 4I2 (dark red) or M. tuberculosis isolate 6C4 (blue). z-
scores are color coded as shown. b C57BL/6 WT BMDMs were generated and infected with M. tuberculosis isolates 4I2 (solid circles) or 6C4 (open
squares), and at the indicated time points, the cell cultures were lysed, RNA extracted, converted to cDNA and subjected to real-time PCR. c C57BL/6 WT
or TLR2 deficient BMDMs were generated and infected with M. tuberculosis isolates 4I2 (solid circles) or 6C4 (open squares). Twenty-four hours post-
infection the culture supernatants were harvested and the amount of IL-1β quantified by ELISA. d THP-1-ASC-GFP monocytes were PMA-differentiated and
left uninfected (NI) or infected with M. tuberculosis isolates 4I2 (solid bars) or 6C4 (open bars) at different MOI, as indicated. Six hours post-infection, cells
were fixed and stained with DAPI prior to image acquisition. The percentage of Speck-positive cells was determined for the different conditions. C57BL/6
WT BMDMs were generated and infected with M. tuberculosis isolates 4I2 (e, f) or 6C4 (g, h) in the absence (0) or presence of increasing doses of NLRP3
(MCC950; e, g) or Caspase-1 (VX-765; f, h) inhibitors. BMDMs were infected with increasing MOI of M. tuberculosis isolate 6C4 (I), with a combination of
both isolates at different doses (j) or with M. tuberculosis isolate 6C4 in the absence (6C4) or presence (6C4+ATP) of 5 mM of ATP (k). e–k Twenty-four
hours post-infection the culture supernatants were harvested and the amount of IL-1β quantified by ELISA. Unless indicated, an MOI of 2 was used for
infections. Represented is the mean ± SEM of triplicate wells for one experiment representative of two (b–j); or for one experiment (k). Statistical analysis
was performed using two-tailed unpaired Student’s t-test (c, k) or One-way ANOVA (d–i) (* p < 0.05; **p < 0.01; ***p < 0.001; and ****p < 0.0001).
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preferentially occurs in the context of a mild TB-associated M.
tuberculosis isolate.
Discussion
M. tuberculosis has been traditionally considered a clone, but
evidence indicates genetic diversity within TB-causing bacteria6.
Here, we provide insights into the functional relevance of M.
tuberculosis diversity, linking variations in the infecting bacteria
to the modulation of host immune responses and clinical
outcomes of TB. Remarkably, across a range of different host
cells, M. tuberculosis isolates recovered from severe TB cases
induced lower cytokine responses as compared to those recovered
from mild TB patients. This finding raises the hypothesis that M.
tuberculosis evolved to fine-tune the immune response, ultimately
modulating the pathogenesis of TB. Therefore, the reason why
some individuals develop severe TB, while others do not, may also
be explained by the characteristics of the infecting bacteria.
Consequently, understanding the underlying bacteria molecular
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bases will prove important from a clinical standpoint. So far, we
did not identify a SNP or group of SNPs associated with the
immunological phenotype or the TB severity at the genome-wide
level, suggesting that the ability of closely related M. tuberculosis
to modulate the host response results from diverse events.
Reflecting that variety of pathways, we have identified signatures
of positive selection when comparing to a large global strain
database. We have also detected an accumulation of SNPs in
genes encoding components or regulators of the ESX-I secretion
system in isolates associated with low IL-1β induction and high
TB severity. This may hence be a hot-spot pathway explored by
the bacteria to thwart full macrophage activation. It will be
interesting to address this hypothesis by systematically generate
M. tuberculosis isogenic strains containing the various SNPs in
ESX-I identified here and probe their functional role in phago-
some rupture and in modulating evasion to macrophage intra-
cellular recognition pathways, as well as their role during in vivo
infection, namely for the development of lung pathology. Pre-
vious studies show that lack of the ESX-I secretion system is
characteristic of avirulent Mycobacteria and that abrogation of
this system renders M. tuberculosis avirulent33. We now disclose
further layers of complexity to this aspect of M. tuberculosis
biology, showing that variations in the efficiency within ESX-I are
likely to exist in highly related isolates, with profound implica-
tions for the pattern recognition pathways triggered in the
infected macrophage and possibly for the outcome of disease. By
restricting phagosome rupture and export of bacterial material to
the cell cytosol, low-cytokine inducing/severe TB M. tuberculosis
isolates prevent the activation of the inflammasome, cGAS, RIG-I,
and other intracellular signaling cascades as revealed by our
global transcriptomic analysis. This is in turn reflected in the
lower induction of IL-1β and type I IFN.
Decreased IL-1β responses are compatible with more severe TB
outcomes. Deficiencies in IL-1β production are associated with
increased susceptibility of TB, both in humans and in mouse
models. A multitude of mechanisms explain the protective role of
IL-1 in TB, from enhancing the macrophage control of intracel-
lular bacterial replication, to driving ILC3 responses required for
early protection34, orchestrating the relocalization of alveolar
macrophages to lung interstitium35 and limiting the proportion
of infected cells and dissemination36. It is therefore not surprising
that a professional pathogen such as M. tuberculosis manipulates
the IL-1 pathway to delay protective mechanisms, and possibly
promote dissemination and/or more severe lung lesions. Inter-
estingly, the patient infected with the low IL-1β-inducing M.
tuberculosis isolate 6C4 had extensive lung pathology, which
included pleural involvement, thus suggesting initial dissemina-
tion events. Of note, a recent study has shown that modern
strains of L4 induced higher IL-1β than ancient strains of lineages
1 and 5, and that this high IL-1β correlated with enhanced
autophagy of infected macrophages37. Importantly, this enhanced
IL-1β/autophagy axis did not result in bacterial control at the
macrophage level37. It will be interesting to, based on our data
and clinical isolates, investigate if in vivo similar mechanisms
operate and what their consequences for the course of infection
might be. Excessive IL-1β production may also be detrimental to
the host, associating with more severe TB disease and increased
lung damage38–42. From the pathogen’s perspective, M. tubercu-
losis isolates that trigger high IL-1β responses would face the risk
of being eliminated during early stages of infection, thus failing
later transmission. It is thus tempting to speculate that the host-
M. tuberculosis parallel evolution has perfected a mechanism that
simultaneously controls IL-1β and its regulator IFN-β, which
ultimately benefits both the host by keeping the infection and
associated immune pathology at check, and the pathogen, by
ensuring transmission.
Collectively, our study bears important consequences for future
TB research. Host genetic or secondary immune suppression have
been associated with higher TB susceptibility. We now show that
the initial immune response is also modulated by differences in
closely related M. tuberculosis. This finding calls for the inclusion
of M. tuberculosis genetic diversity and continuous evolution as
part of human genetic association studies, as well as of vaccine
design and as an important component to consider in the
development of host-directed therapies, such as those that
interfere with the levels of IL-1β or other cytokines.
Methods
Ethics statement for Human sample collection. The study protocol leading to
PBMC isolation was approved by the Health Ethics Committees of the CHSJ
(approval number 109-11), the North Health Region Administration (approval
number 71-2014) and the Portuguese Data Protection Authority (approval number
12174-2011). To ensure confidentiality, each case was anonymized by the assign-
ment of a random identification number. Participants were enrolled at a TB clinic
in Porto and provided informed consent. Experiments were conducted according
to the principles expressed in the Declaration of Helsinki.
Animals. Eight-to-12-week-old male or female mice used to generate BMDMs
were of the following origins: C57BL/6 WT, TLR2-/- and TLR4-/- mice were
maintained and provided by the animal facility of i3S; IFNAR-/- and matched
C57BL/6 WT were kindly provided by Dr. Jocelyne Demangeau, IGC, Oeiras,
Portugal; AIM2-/- and matched C57BL/6 WT femurs were kindly provided by Dr.
Thomas Henry, CIRI-Center International de Recherche en Infectiologie
(INSERM), Lyon, France, under the MTA OM-217356. Animals were kept under
specific-pathogen free conditions, with controlled temperature (20–24 °C),
humidity (45–65%), light cycle (12 h light/dark) and ad libitum food and water. All
experiments were performed in strict accordance with recommendation of Eur-
opean Union Directive 2010/63/EU and previously approved by Portuguese
National Authority for Animal Health—Direção Geral de Alimentação e Veter-
inária (DGAV).
Fig. 6 M. tuberculosis isolate 6C4 evades macrophage cytosolic surveillance pathways. a Heatmap representing the expression of genes associated with
the cGAS pathway in non-infected BMDMs (NI; yellow) and BMDMs infected with M. tuberculosis isolate 4I2 (dark red) or M. tuberculosis isolate 6C4
(blue). z-scores are color coded as shown. C57BL/6 WT BMDMs were generated and infected with b M. tuberculosis isolates 4I2 (solid bars) or 6C4 (open
bars) or c with M. tuberculosis isolate 4I2 in the absence (0) or presence of different doses of the cGAS inhibitor RU521. Six hours post-infection, the cell
cultures were lysed, RNA extracted, converted to cDNA, and subjected to real-time PCR to quantify the expression of the indicated genes. d C57BL/6 WT
or AIM2 deficient (-/-) BMDMs were generated and infected with M. tuberculosis isolates 4I2 (solid bars) or 6C4 (open bars). Infection of C57BL/6 WT
BMDMs in the absence (-) or presence (+) of (e) a K+ channel inhibitor (glybenclamide; 25 µgmL–1), f a cathepsin B (CatB) inhibitor (ZRLR; 10 µM) or g a
phagocytosis inhibitor (cytochalasin D; 5 µM). h–i C57BL/6 WT BMDMs were generated and infected with live or rifampicin (RIF)-treated M. tuberculosis
isolates 4I2 (solid bars) or 6C4 (open bars). d–h Twenty-four hours post-infection, the culture supernatants were harvested and the amount of IL-1β
quantified by ELISA. i Six hours post-infection the cell cultures were lysed, RNA extracted, converted to cDNA, and subjected to real-time PCR to quantify
the expression of Ifnb. Represented is the mean ± SEM of triplicate wells from one experiment representative of two (b, c, g); from two (d, e, h) or one (f, i)
independent experiments. c Represented is the % of inhibition for the expression of each gene in BMDMs infected with M. tuberculosis isolate 4I2 in the
presence of RU.521 relatively to those infected in the absence of the cGAS inhibitor. An MOI of 2 was used for all infections. Statistical analysis was
performed using two-tailed unpaired Student’s t-test (*p < 0.05; **p < 0.01; ***p < 0.001; and ****p < 0.0001).
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Study population. A cohort of 813 culture-confirmed TB cases diagnosed at a
University-affiliated hospital (CHSJ, Porto) during a 7 years (2007–2013) period
was reviewed to derive a study group of pulmonary TB cases (Supplementary Fig.
4a). The overall demographic and clinical features of this population have been
described10. Patients in the study group were divided into four main groups: no
known comorbidities (TB group); HIV-coinfected (HIV-TB group); diabetics
(DM-TB group); other comorbidities or immunological suppression, including
hepatitis C virus chronic infection, alcohol abuse, end-stage chronic kidney failure,
malignancy, cirrhosis or chronic liver failure, heart failure, chronic obstructive
pulmonary disease, and patients with structural lung disease, such as silicosis,
fibrosis, or bronchiectasis (other).
Clinical severity classification. The clinical records of the patients in the TB
group were retrospectively reviewed to stratify the severity of TB at presentation.
First, digital images of plain chest radiographs were blind-graded by two inde-
pendent clinicians, using a previously published decision tree (Supplementary Fig.
1b13), based on the lesions extent, the presence of lung cavitation and pleural
effusion. Minimal lesions were cases of single hilar enlargement, or minimal pul-
monary infiltrates. Moderate disease had cavitations up to 4 cm, or pleural effusion
extending to less than within 2 cm of carina, or lesions of slight to moderate density
of total extent not greater than total equivalent volume of one lung, or dense and
confluent lesions occupying less than one-third of one lung. Advanced disease
exceeds criteria for moderate. Disagreements between the two clinicians were
resolved through a consensus assessment by a third reader. To take a broader view
of the disease clinical severity, a classification flowchart was developed (Fig. 1c)
where chest X-ray findings were combined with measures of inflammatory con-
sumption and overall nutritional status (baseline levels of hemoglobin and C-
reactive protein), as well as severity of symptoms.
Human ancestry. Individual ancestry estimates were computed using Structure41
considering four ancestral contributors (African, European, East Asian and Native
American biogeographical origins; K= 4); known genotypes from the HGDP-
CEPH panel11 and the 1000 Genomes42, complemented with Colombian43–45 and
Peruvian Amerindians (unpublished data), were used as learning reference samples
to perform unsupervised clustering analyses of Portuguese controls (Porto TB-
contacts) and TB patients (Porto TB-cohort) (100,000 burnin followed by 100,000
MCMC repetitions; three replicate runs). Aligned averaged clustering was then
obtained with CLUMPP44 and plotted with DISTRUCT45.
Recovery of M. tuberculosis clinical isolates. Bacterial samples (n= 133) of the
subjects in the TB group were recovered from stored primary cultures of M.
tuberculosis clinical isolates at the Clinical Microbiology department of CHSJ. Two
hundred mmicroliters of inoculum were plated and smeared uniformly on solid
Mycobacteria 7H11 agar supplemented with 10% Oleic Albumin Dextrose Catalase
Growth Supplement (OADC), 0,5% glycerol, and PANTA antibiotic mixture. The
plates were incubated at 37 °C for 4 to 8 weeks. Grown colonies were gently rubbed
and transferred to 20 mL of Middlebrook 7H9 liquid medium (BD Biosciences, San
Jose, USA) supplemented with 10% OADC, 0,2% glycerol and 0.05% Tween® 80
(Sigma-Aldrich, St. Louis, USA). Alternatively, the stored primary cultures were re-
grown in MGIT tubes using a BACTEC instrument (BD) and once a positive signal
was obtained, transferred to 20 mL of Middlebrook 7H9 liquid medium, as stated
above. All Middlebrook 7H9 liquid cultures were incubated at 37 °C with constant
120 rpm shaking for an additional 7–10 days, to increase the bacterial biomass.
Preparation of bacterial stocks. Twenty-six selected M. tuberculosis clinical iso-
lates (Supplementary Table 1) were grown in 200 mL of Middlebrook 7H9 liquid
medium supplemented with 10% OADC and 0,2% glycerol. Bacterial suspensions
were aliquoted in cryovials, frozen, and stored at –80 °C. Bacterial quantification
was performed by thawing three to five vials and plating several serial dilutions in
7H11 agar medium supplemented with 10% OADC and 0.5% glycerol. The plates
were incubated 21 to 28 days at 37 °C before colony count.
M. tuberculosis genomic DNA extraction. Bacterial suspensions were pelleted,
resuspended in water to a final volume of 1 mL and inactivated with 0.5 mL of a 1:2
phenol-water solution for DNA extraction and homogenized with zirconia beads in
TEN buffer, in the Fast-Prep24 bead beater (MP Biomedicals) at 4 M s-1 for 30 s,
twice. DNA was then extracted with chlorophorm, precipitated with absolute
ethanol and sodium acetate, resuspended in TE buffer, quantified by spectro-
photometry (NanoDrop® 1000, Thermo Scientific, Wilmington, USA) and nor-
malized to a standard concentration of 200 ng μL–1.
MTBC lineage and sublineage genotyping. MTBC lineage and sublineage gen-
otyping was performed by a custom TaqMan® real-time PCR assay (Applied
Biosystems, Carlsbad, USA), using SNPs as stable genetic markers, as previously
described46. Results were analyzed with the Bio-Rad CFX Manager™ 3.1 and
genotypes determined using the Allele Discrimination tool.
Whole-genome sequencing and analysis. DNA sequencing of bacterial isolates
was performed with Illumina MiSeq and HiSeq 2000/2500 paired-end technology.
Raw reads were subjected to quality trimming with Trimmomatic47 v0.38 (mini-
mum read length 20 and average base quality 20 in 4-base sliding windows). Visual
inspection after trimming was performed with FastQC (https://www.
bioinformatics.babraham.ac.uk/projects/fastqc) v0.11.7 and MultiQC48 v1.0. Fil-
tered reads were mapped to the reconstructed MTBC ancestral strain5 with bwa-
mem49 and converted to BAM files with SAMtools50 v.1.3.1. Duplicated reads were
removed with Picard (http://broadinstitute.github.io/picard) Mark Duplicates
v2.18.14. Single nucleotide polymorphisms and insertions/deletions were called
with Pilon51 v1.22 (minimum depth of five valid read pairs, minimum mapping
quality 20 and minimum base quality 20) and filtered with bcftools (http://
samtools.github.io/bcftools) v1.3.1 (keeping only biallelic sites with variant fre-
quency >75% and with a minimum distance from indels of four nucleotides).
Genomic variants were annotated with SnpEff52 v4.3t according to the M. tuber-
culosis H37Rv reference genome annotation (NC_000962.3; GCF_000195955.2).
To minimize false positives, previously identified repetitive genomic regions,
mobile elements and genes containing ≥50 bp nucleotide chunks identical to other
parts of the genome53,54 were not considered to further analysis. Variants exclusive
from either low or high IL-1β-inducing strains were assigned only on sites that had
the reference allele successfully called on all the isolates belonging to the opposite
phenotype.
Phylogenetic reconstruction was derived from a multiple sequence alignment
containing only single nucleotide polymorphisms (n= 10,748) and allowing <5%
of strains per site with missing information. Maximum likelihood (ML) tree was
obtained with RaxML55 v7.2.8 using GTR GAMMA model with estimate of
proportion of invariable sites, 1000 rapid bootstrap replicates and searching for the
best-scoring ML tree. Tree was rooted on the MTBC ancestor and annotated using
iTOL56 v4.3.3.
The global reference dataset was constructed with samples from3,15,19,57–63. We
applied the pipeline explained above to derive an alignment and a phylogeny with
all the downloaded samples (n= 9240). After that, we run Treemer64 to reduce the
number of strains with a minimum loss of genetic diversity (0.05 of the initial
diversity). The final alignment consisted in 4528 MTBC strains. Variants identified
in the Porto dataset were mapped to the phylogeny and the number of occurrences
(homoplasies) across the phylogeny was recorded.
Cell wall analysis. M. tuberculosis isolates 4I2 and 6C4 were grown in Mid-
dlebrook 7H9 liquid medium complemented with 10% OADC and 0.2% glycerol
until a dense bacteria suspension was obtained. The bacteria were pelleted by
centrifugation and inactivated by autoclave sterilization before lipid extraction.
Polar and apolar lipids were extracted using described methods65. Extracted lipids
were resuspended in chloroform:methanol (2:1). Free and apolar lipid extracts
using a solvent systems consisting of chloroform/methanol/water (60:16:2). A 2D
TLC system B (direction 1: Petroleum ether 60–80/acetone (92:8)–3 runs; direction
2: toluene/acetone (95:5)–1 run) and system C (direction 1: chloroform/methanol
(96:4)–1 run; direction 2: toluene/acetone (80:20)–1 run) were also used. Ten
percent phosphomolybdic acid staining followed by charring was used to reveal
lipids in TLCs.
PBMC isolation and CD14+ cell purification. Blood from donors was collected
and processed within 2 h. PBMCs were separated using Histopaque 1077 at room
temperature (Sigma-Aldrich) and following the protocol for mononuclear cell
separation of SepMate-50 tubes (StemCells). Cells were resuspended in complete
RPMI-1640 medium (10% Fetal bovine serum, 1% sodium pyruvate, 1% HEPES
and 1% L-glutamine; cRPMI) (GIBCO), counted and plated in 24-well plates at a
concentration of 0.5 × 106 cell mL–1 in 500 μl of cRPMI.
CD14+ cells were isolated from cryopreserved PBMCs. PBMCs were magnetic
labeled with CD14 MicroBeads (Miltenyi Biotec) and isolated through positive
selection using MACS Separation Columns MS (Miltenyi Biotec), according to the
manufacturer’s protocol. Purified cells (~95% pure) were counted and plated in 96
well plates at a concentration of 0.5 × 106 cell mL–1 in 200 μl of cRPMI (GIBCO).
THP-1-ASC-GFP culture. The THP-1-ASC-GFP (InvivoGen) cell line was main-
tained in cRPMI (GIBCO) supplemented with 100 µg mL–1 Zeocin (InvivoGen), at
37 °C and 5% CO2. Cells were used before reaching 20 passages.
BMDM generation. Protocols were as previously published66. Briefly, mice tibias
and femurs were collected and bone marrow flushed with complete DMEM
medium (10% Fetal bovine serum, 1% sodium pyruvate, 1% HEPES and 1% L-
glutamine; cDMEM) (GIBCO). Cells were counted and plated in Petri dishes at the
concentration of 0.5 × 106 cells mL–1 in 8 mL with 20% L-cell conditioned medium
(V/V). On day 4, cDMEM supplemented with 20% LCCM was added to the cells.
On day 7, cells were harvested, counted, plated in 24-well plates at a concentration
of 1 × 106 cell mL–1 in 500 μl of cDMEM.
In vitro infections. Before infection, mycobacterial clumps were disaggregated by
gentle passaging through a 25G needle. For PBMC infection, a MOI of 1 bacteria: 1
cell (MOI of 1) was used for infection. THP-1-ASC-GFP cells were primed with
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100 nM PMA for 24 h, and allowed to rest for 4 days in fresh medium without
PMA, before being infected. MOIs of 1 or 0.1 were used for infection of THP-1-
ASC-GFP cells. BMDMs were infected with a MOI of 2. For specific experiments,
MOIs of 0.5, 1, 1.5, 5, and 10 were used to infect BMDMs. At different time points,
cells or supernatants were recovered for RNA or protein analysis. Culture super-
natants were filter sterilized prior to be used for protein detection. For immuno-
fluorescent detection of ASC specks, infected cells were washed with PBS and fixed
with formalin 2%. For RIF treatment condition, bacteria were treated with 500 µg
mL–1 of antibiotic for 18–24 h before been pelleted. Loss of viability was confirmed
by plating treated bacteria on 7H11 agar plates.
THP-1 ASC speck quantification. Fixed cells were stained with DAPI and an IN
CELL analyzer 2000 was used for plate image acquisition. Images were analyzed
using Fiji67.
Chemical inhibitors or agonists. For specific experiments, cells were treated with
0.1, 1, or 10 µM of the NLRP3 inhibitor, MCC950 (InvivoGen), or the caspase-1
inhibitor, VX-760 (InvivoGen); 10 or 20 µM of the cGAS inhibitor, RU.521
(InvivoGen); 25 µg mL–1 of the K+ channel inhibitor, Glybenclamide (InvivoGen);
10 µM of the cathepsin B inhibitor, ZRLR (kindly provided by Eva Wieczerzak68);
5 µM of the phagocytosis inhibitor, cytochalasin D (Sigma-Aldrich); or with 5 mM
of ATP (InvivoGen); 1 µg mL–1 of the RIG-I agonist, 5’ppp-dsRNA (InvivoGen).
mRNA analysis by real-time PCR. Total RNA from infected cells was extracted
with TRIzol Reagent (Invitrogen, California, USA), according to the manu-
facturer’s instructions. cDNA was synthesized using the ProtoScript First Strand
cDNA Synthesis kit (New England Biolabs, Massachusetts, USA) and gene
expression was analyzed by RT-PCR using the Bio-Rad CFX Manager™ 3.1, as
describe before69. Targeted Il1β, Ifnβ, Tnf, and Il10 mRNA expression was quan-
tified using SYBR Green (Thermo Fisher) and specific oligonucleotides, and nor-
malized to ubiquitin mRNA levels. Ccl2 and Cxcl10 mRNA expression was
quantified using TaqMan gene expression master mix (Applied Biosystems), and
normalized to hypoxanthine phosphoribosyltransferase (HPRT). Oligonucleotide
information is in Supplementary Table 5.
Cytokine detection. Cytokines were detected in supernatants of in vitro infected
cultures by immunoassay. This included Multiplex (Invitrogen) for human IL-1β,
IL-12p40, IL-10, and IFN-β (catalog numbers EPX01A-10224-901, EPX01A-
12090-901, EPX01A-10215-901, and EPX01A-12088-901, respectively; all with the
human basic kit, cat number EPX010-10420-901), or ELISA for mouse IL-1β
(Invitrogen; BMS6002TEN), IFN-β (BioLegend; 439407) and TNF (Invitrogen;
BMS607-3TEN) as indicated in the Figure legends.
Global transcriptomic and pathway analyses. Total RNA from infected or non-
infected cells was extracted as above and treated with Turbo DNA-free kit (Invi-
trogen) before sequencing. Targeted RNA sequencing was performed by GenCore,
i3S (Institute of Health Innovation and Research) using Ion AmpliSeq™ Tran-
scriptome Mouse Gene Expression Kit. All subsequent analyses were performed in
R [v3.5.1]. RNA expression levels in the count matrix were normalized using the
trimmed mean of M-values and computed as counts per million using edgeR
package [v3.24.1]70,71. Differential expression analysis was performed using edgeR
and limma [v3.38.3]72 packages. Genes with <15 raw counts in all samples were
excluded. Differentially expressed genes were determined through linear model
fitting. Empirical Bayes moderated t-statistics test was performed and genes with
adjusted p-value ≤ 0.05 and log2 fold-change ≤ –2 or ≥2 were considered sig-
nificant. Pathway analysis was performed using ReactomePA package [v1.26.0]73.
Adjustment of p-values for multiple testing was performed using the
Benjamini–Hochberg (BH) procedure74 in both differential expression analysis and
pathway analysis.
Quantification and statistical analysis. Data were analyzed using GraphPad
Prism software, version 8.1.0. Reference to “n” is in Figure legends. Unpaired, two-
tailed Student’s t-test was used to determine differences between two different
groups and one-way ANOVA for more than two groups. Post-tests were applied to
multiple comparisons as referred in Figure legends. Data was checked for normality
and log normality. Other statistical tests included Fisher’s exact test and Pearson
correlation, as indicated in the Figure legends. Pearson’s r was calculated to
examine relationships between the concentration of ex vivo-induced cytokines (IL-
1β, IL-12p40, or IL-10) and the TB presentation (mild, moderate, or severe) in the
patients from which the bacteria were isolated. Differences were considered sig-
nificant for p ≤ 0.05 and represented as follows: *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001
and ****p ≤ 0.0001. Bean plots were generated with the R package beanplot75.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Sequence data are deposited on NCBI GEO database with the accession code GSE138580.
All other data are available from the corresponding author upon reasonable request. Raw
data for the figures are available as a Source Data file.
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